Positive impact of molecular analysis on prognostic scores in essential thrombocythemia: a single center prospective cohort experience.
作者信息
Luque Paz Damien Luque, Mansier Olivier, Riou Jérémie, Conejero Carole, Roy Lydia, Belkhodja Célia, Ugo Valérie, Giraudier Stéphane
机构信息
Université Angers, UFR Santé.
CHU d'Angers, Laboratoire d'Hématologie.
出版信息
Haematologica. 2019 Apr;104(4):e134-e137. doi: 10.3324/haematol.2018.197699. Epub 2018 Oct 18.
Abstract
摘要
相似文献
1
Positive impact of molecular analysis on prognostic scores in essential thrombocythemia: a single center prospective cohort experience.分子分析对原发性血小板增多症预后评分的积极影响：一项单中心前瞻性队列研究经验
Haematologica. 2019 Apr;104(4):e134-e137. doi: 10.3324/haematol.2018.197699. Epub 2018 Oct 18.
2
Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome.原发性血小板增多症和原发性骨髓纤维化的突变状态决定临床结局。
Haematologica. 2016 Apr;101(4):e129-32. doi: 10.3324/haematol.2015.138958. Epub 2016 Jan 14.
3
Distinct driver mutation profiles of childhood and adolescent essential thrombocythemia.儿童及青少年原发性血小板增多症不同的驱动基因突变谱
Pediatr Blood Cancer. 2015 Jan;62(1):175-6. doi: 10.1002/pbc.25190. Epub 2014 Aug 17.
4
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.伴有CALR或JAK2突变的原发性血小板增多症的表型与预后分析。
Haematologica. 2015 Jul;100(7):893-7. doi: 10.3324/haematol.2014.118299. Epub 2015 May 1.
5
JAK2, MPL, and CALR mutations in children with essential thrombocythemia.原发性血小板增多症患儿的JAK2、MPL和CALR基因突变
Int J Hematol. 2016 Aug;104(2):266-7. doi: 10.1007/s12185-016-2022-2. Epub 2016 May 21.
6
Distinct molecular abnormalities underlie unique clinical features of essential thrombocythemia in children.不同的分子异常是儿童原发性血小板增多症独特临床特征的基础。
Leukemia. 2016 Mar;30(3):746-9. doi: 10.1038/leu.2015.167. Epub 2015 Jun 29.
7
Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia.钙网织蛋白变异体分层驱动基因突变状态和预后在原发性血小板增多症。
Am J Hematol. 2016 May;91(5):503-6. doi: 10.1002/ajh.24338. Epub 2016 Apr 4.
8
CALR and ASXL1 mutation analysis in 190 patients with essential thrombocythemia.190例原发性血小板增多症患者的CALR和ASXL1基因突变分析。
Leuk Lymphoma. 2015 Mar;56(3):820-2. doi: 10.3109/10428194.2014.939963. Epub 2014 Aug 13.
9
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.217 例原发性骨髓纤维化或特发性血小板增多症青年患者的突变和长期结局。
Leukemia. 2015 Jun;29(6):1344-9. doi: 10.1038/leu.2015.87. Epub 2015 Mar 24.
10
Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status.接受阿那格雷治疗的原发性血小板增多症患者的长期随访：根据JAK2/CALR/MPL突变状态进行亚组分析。
Eur J Haematol. 2016 Apr;96(4):435-42. doi: 10.1111/ejh.12614. Epub 2015 Jul 19.
引用本文的文献
1
Relationship between additional mutations at diagnosis and treatment response in patients with essential thrombocythemia.原发性血小板增多症患者诊断时的额外突变与治疗反应之间的关系。
Blood Adv. 2025 Mar 25;9(6):1303-1311. doi: 10.1182/bloodadvances.2024014791.
2
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.具有不同临床和分子特征的动静脉血栓形成评分系统用于骨髓增殖性肿瘤的危险分层。
Leukemia. 2024 Feb;38(2):326-339. doi: 10.1038/s41375-023-02114-5. Epub 2023 Dec 27.
3
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation.骨髓纤维化和原发性血小板增多症向白血病的演变：基因组特征可预测转化时间。
Blood Adv. 2020 Oct 13;4(19):4887-4897. doi: 10.1182/bloodadvances.2020002271.
4
Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses.骨髓增殖性肿瘤中的下一代测序。过去的经验教训以及用作预后和治疗反应预测指标的前景。
Cancers (Basel). 2020 Aug 6;12(8):2194. doi: 10.3390/cancers12082194.
5
Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.在真实环境中，阿那格雷作为细胞减少治疗初治原发性血小板增多症患者的一线药物的疗效和安全性。
Eur J Haematol. 2019 Aug;103(2):116-123. doi: 10.1111/ejh.13265. Epub 2019 Jun 17.
本文引用的文献
1
Targeted deep sequencing in polycythemia vera and essential thrombocythemia.真性红细胞增多症和原发性血小板增多症中的靶向深度测序
Blood Adv. 2016 Nov 22;1(1):21-30. doi: 10.1182/bloodadvances.2016000216. eCollection 2016 Nov 29.
2
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.MIPSS70：原发性骨髓纤维化移植年龄患者的突变增强国际预后评分系统。
J Clin Oncol. 2018 Feb 1;36(4):310-318. doi: 10.1200/JCO.2017.76.4886. Epub 2017 Dec 9.
3
Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia.基因型对真性红细胞增多症和原发性血小板增多症白血病转化的影响。
Br J Haematol. 2017 Sep;178(5):764-771. doi: 10.1111/bjh.14762. Epub 2017 May 23.
4
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.2016 年 WHO 诊断的前纤维化和显性原发性骨髓纤维化患者的表现和转归。
Blood. 2017 Jun 15;129(24):3227-3236. doi: 10.1182/blood-2017-01-761999. Epub 2017 Mar 28.
5
Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome.真性红细胞增多症和原发性血小板增多症中18个基因的序列分析揭示了突变状态与临床结果之间的关联。
Genes Chromosomes Cancer. 2017 May;56(5):354-362. doi: 10.1002/gcc.22437. Epub 2017 Feb 1.
6
Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome.原发性血小板增多症和原发性骨髓纤维化的突变状态决定临床结局。
Haematologica. 2016 Apr;101(4):e129-32. doi: 10.3324/haematol.2015.138958. Epub 2016 Jan 14.
7
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients.三阴性原发性血小板增多症患者存在非典型的血小板生成素受体（MPL）突变。
Blood. 2016 Jan 21;127(3):333-42. doi: 10.1182/blood-2015-07-661983. Epub 2015 Oct 8.
8
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.CALR 突变型骨髓增殖性肿瘤中不同突变亚型的临床差异效应。
Leukemia. 2016 Feb;30(2):431-8. doi: 10.1038/leu.2015.277. Epub 2015 Oct 9.
9
Effect of mutation order on myeloproliferative neoplasms.突变顺序对骨髓增殖性肿瘤的影响。
N Engl J Med. 2015 Feb 12;372(7):601-612. doi: 10.1056/NEJMoa1412098.
10
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms.骨髓增殖性肿瘤白血病转化的基因组和功能分析
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5401-10. doi: 10.1073/pnas.1407792111. Epub 2014 Dec 2.
Zotero 插件